etoposide phosphate has been researched along with Metastase in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Al-Rohil, RN; Bentley, RC; Cardona, DM; Feng, X; Jour, G; Shen, G; Underwood, CIM | 1 |
Braybrooke, JP; Davis, T; Harris, AL; Joel, S; Levitt, NC; Madhusudan, S; Talbot, DC; Turley, H; Wilner, S | 1 |
2 other study(ies) available for etoposide phosphate and Metastase
Article | Year |
---|---|
Epithelioid Hyalinizing Sarcoma With MGA-NUTM1 Fusion.
Topics: Antineoplastic Combined Chemotherapy Protocols; Basic Helix-Loop-Helix Transcription Factors; Cyclophosphamide; Dactinomycin; Etoposide; Foot; Foot Bones; Gene Fusion; Humans; Hyalin; Ifosfamide; Magnetic Resonance Imaging; Male; Middle Aged; Muscle, Skeletal; Neoplasm Metastasis; Neoplasm Proteins; Neoplasm Recurrence, Local; Nuclear Proteins; Organophosphorus Compounds; Sarcoma; Vincristine | 2020 |
Pharmacokinetic study of cisplatin and infusional etoposide phosphate in advanced breast cancer with correlation of response to topoisomerase IIalpha expression.
Topics: Adult; Aged; Antigens, Neoplasm; Antineoplastic Agents; Breast Neoplasms; Cisplatin; Cohort Studies; Disease Progression; DNA Topoisomerases, Type II; DNA-Binding Proteins; Etoposide; Female; Humans; Immunohistochemistry; Infusions, Intravenous; Middle Aged; Neoplasm Metastasis; Organophosphorus Compounds; Receptors, Estrogen; Time Factors | 2003 |